{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:21:47Z","timestamp":1740147707658,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR000458"],"award-info":[{"award-number":["KL2TR000458"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11764-020-00860-4","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T20:02:48Z","timestamp":1581364968000},"page":"417-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Communicating cardiovascular risk to high-risk cancer survivors: a mixed-methods pilot study of a statin risk communication tool"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-247X","authenticated-orcid":false,"given":"Nirupa J.","family":"Raghunathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassim","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Oeffinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily S.","family":"Tonorezos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Korenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"issue":"14","key":"860_CR1","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1200\/jco.2008.21.1425","volume":"27","author":"GT Armstrong","year":"2009","unstructured":"Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2328\u201338. https:\/\/doi.org\/10.1200\/jco.2008.21.1425.","journal-title":"J Clin Oncol"},{"issue":"15","key":"860_CR2","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572\u201382. https:\/\/doi.org\/10.1056\/NEJMsa060185.","journal-title":"N Engl J Med"},{"issue":"4","key":"860_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","volume":"42","author":"PA Heidenreich","year":"2003","unstructured":"Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42(4):743\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"860_CR4","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/0002-9149(87)90345-6","volume":"60","author":"PT McEniery","year":"1987","unstructured":"McEniery PT, Dorosti K, Schiavone WA, Pedrick TJ, Sheldon WC. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol. 1987;60(13):1020\u20134.","journal-title":"Am J Cardiol"},{"issue":"6","key":"860_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1200\/jco.2009.25.2627","volume":"28","author":"S Kupeli","year":"2010","unstructured":"Kupeli S, Hazirolan T, Varan A, Akata D, Alehan D, Hayran M, et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin\u2019s lymphoma. J Clin Oncol. 2010;28(6):1025\u201330. https:\/\/doi.org\/10.1200\/jco.2009.25.2627.","journal-title":"J Clin Oncol"},{"issue":"1","key":"860_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/jco.2006.07.0805","volume":"25","author":"PA Heidenreich","year":"2007","unstructured":"Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease. J Clin Oncol. 2007;25(1):43\u20139. https:\/\/doi.org\/10.1200\/jco.2006.07.0805.","journal-title":"J Clin Oncol"},{"issue":"21","key":"860_CR7","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","volume":"290","author":"MC Hull","year":"2003","unstructured":"Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. Jama. 2003;290(21):2831\u20137. https:\/\/doi.org\/10.1001\/jama.290.21.2831.","journal-title":"Jama."},{"issue":"1","key":"860_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/jco.2017.74.8673","volume":"36","author":"EJ Chow","year":"2018","unstructured":"Chow EJ, Chen Y, Hudson MM, Feijen EAM, Kremer LC, Border WL, et al. Prediction of ischemic heart disease and stroke in survivors of childhood cancer. J Clin Oncol. 2018;36(1):44\u201352. https:\/\/doi.org\/10.1200\/jco.2017.74.8673.","journal-title":"J Clin Oncol"},{"key":"860_CR9","doi-asserted-by":"publisher","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults\u2014a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 2014;63(25_PA). https:\/\/doi.org\/10.1016\/j.jacc.2013.11.002.","DOI":"10.1016\/j.jacc.2013.11.002"},{"issue":"3","key":"860_CR10","doi-asserted-by":"publisher","first-page":"e00145","DOI":"10.1002\/prp2.145","volume":"3","author":"M Lenarczyk","year":"2015","unstructured":"Lenarczyk M, Su J, Haworth ST, Komorowski R, Fish BL, Migrino RQ, et al. Simvastatin mitigates increases in risk factors for and the occurrence of cardiac disease following 10 Gy total body irradiation. Pharmacol Res Perspect. 2015;3(3):e00145. https:\/\/doi.org\/10.1002\/prp2.145.","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"860_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cjca.2014.11.020","volume":"31","author":"R Chotenimitkhun","year":"2015","unstructured":"Chotenimitkhun R, D'Agostino R Jr, Lawrence JA, Hamilton CA, Jordan JH, Vasu S, et al. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function. Can J Cardiol. 2015;31(3):302\u20137. https:\/\/doi.org\/10.1016\/j.cjca.2014.11.020.","journal-title":"Can J Cardiol"},{"key":"860_CR12","doi-asserted-by":"publisher","unstructured":"Marlatt KL, Steinberger J, Rudser KD, Dengel DR, Sadak KT, Lee JL, et al. The effect of atorvastatin on vascular function and structure in young adult survivors of childhood cancer: a randomized, placebo-controlled pilot clinical trial. J Adolesc Young Adult Oncol. 2017. https:\/\/doi.org\/10.1089\/jayao.2017.0075.","DOI":"10.1089\/jayao.2017.0075"},{"issue":"1","key":"860_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5853\/jos.2017.01802","volume":"20","author":"D Addison","year":"2018","unstructured":"Addison D, Lawler PR, Emami H, Janjua SA, Staziaki PV, Hallett TR, et al. Incidental statin use and the risk of stroke or transient ischemic attack after radiotherapy for head and neck cancer. J Stroke. 2018;20(1):71\u20139. https:\/\/doi.org\/10.5853\/jos.2017.01802.","journal-title":"J Stroke"},{"issue":"13","key":"860_CR14","doi-asserted-by":"publisher","first-page":"e005996","DOI":"10.1161\/jaha.117.005996","volume":"8","author":"J Boulet","year":"2019","unstructured":"Boulet J, Pena J, Hulten EA, Neilan TG, Dragomir A, Freeman C, et al. Statin use and risk of vascular events among cancer patients after radiotherapy to the thorax, head, and neck. J Am Heart Assoc. 2019;8(13):e005996. https:\/\/doi.org\/10.1161\/jaha.117.005996.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"860_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/maj.0000000000000292","volume":"348","author":"CM Gamboa","year":"2014","unstructured":"Gamboa CM, Safford MM, Levitan EB, Mann DM, Yun H, Glasser SP, et al. Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease. Am J Med Sci. 2014;348(2):108\u201314. https:\/\/doi.org\/10.1097\/maj.0000000000000292.","journal-title":"Am J Med Sci"},{"issue":"5","key":"860_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jacl.2016.06.011","volume":"10","author":"ND Wong","year":"2016","unstructured":"Wong ND, Young D, Zhao Y, Nguyen H, Caballes J, Khan I, et al. Prevalence of the American College of Cardiology\/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012. J Clin Lipidol. 2016;10(5):1109\u201318. https:\/\/doi.org\/10.1016\/j.jacl.2016.06.011.","journal-title":"J Clin Lipidol"},{"key":"860_CR17","volume-title":"Crossing the quality chasm: a new health system for the 21st century","author":"Institute of Medicine Committee on Quality of Health Care in A","year":"2001","unstructured":"Institute of Medicine Committee on Quality of Health Care in A. Crossing the quality chasm: a new health system for the 21st century. Washington (DC): National Academies Press (US); 2001."},{"issue":"6","key":"860_CR18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1197\/jamia.M2115","volume":"13","author":"JS Ancker","year":"2006","unstructured":"Ancker JS, Senathirajah Y, Kukafka R, Starren JB. Design features of graphs in health risk communication: a systematic review. J Am Med Inform Assoc. 2006;13(6):608\u201318. https:\/\/doi.org\/10.1197\/jamia.M2115.","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"860_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/m14-0295","volume":"161","author":"DA Zipkin","year":"2014","unstructured":"Zipkin DA, Umscheid CA, Keating NL, Allen E, Aung K, Beyth R, et al. Evidence-based risk communication: a systematic review. Ann Intern Med. 2014;161(4):270\u201380. https:\/\/doi.org\/10.7326\/m14-0295.","journal-title":"Ann Intern Med"},{"issue":"1","key":"860_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pec.2009.10.008","volume":"80","author":"DM Mann","year":"2010","unstructured":"Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T. The statin choice decision aid in primary care: a randomized trial. Patient Educ Couns. 2010;80(1):138\u201340. https:\/\/doi.org\/10.1016\/j.pec.2009.10.008.","journal-title":"Patient Educ Couns"},{"issue":"3","key":"860_CR21","doi-asserted-by":"publisher","first-page":"e0150205","DOI":"10.1371\/journal.pone.0150205","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PloS One. 2016;11(3):e0150205. https:\/\/doi.org\/10.1371\/journal.pone.0150205.","journal-title":"PloS One"},{"issue":"10","key":"860_CR22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/archinte.167.10.1076","volume":"167","author":"AJ Weymiller","year":"2007","unstructured":"Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167(10):1076\u201382. https:\/\/doi.org\/10.1001\/archinte.167.10.1076.","journal-title":"Arch Intern Med"},{"issue":"1","key":"860_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0272989x9501500105","volume":"15","author":"AM O'Connor","year":"1995","unstructured":"O'Connor AM. Validation of a decisional conflict scale. Med Decis Mak. 1995;15(1):25\u201330. https:\/\/doi.org\/10.1177\/0272989x9501500105.","journal-title":"Med Decis Mak"},{"key":"860_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1471-2296-12-141","volume":"12","author":"P Selic","year":"2011","unstructured":"Selic P, Svab I, Repolusk M, Gucek NK. What factors affect patients\u2019 recall of general practitioners\u2019 advice? BMC Fam Pract. 2011;12:141. https:\/\/doi.org\/10.1186\/1471-2296-12-141.","journal-title":"BMC Fam Pract"},{"issue":"5","key":"860_CR25","first-page":"219","volume":"96","author":"RPC Kessels","year":"2003","unstructured":"Kessels RPC. Patients\u2019 memory for medical information. J R Soc Med. 2003;96(5):219\u201322.","journal-title":"J R Soc Med"},{"issue":"2","key":"860_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1086\/269029","volume":"51","author":"JA Krosnick","year":"1987","unstructured":"Krosnick JA, Alwin DF. An evaluation of a cognitive theory of response-order effects in survey measurement. Public Opin Q. 1987;51(2):201\u201319. https:\/\/doi.org\/10.1086\/269029.","journal-title":"Public Opin Q"},{"issue":"30","key":"860_CR27","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1002\/sim.4377","volume":"30","author":"BL Egleston","year":"2011","unstructured":"Egleston BL, Miller SM, Meropol NJ. The impact of misclassification due to survey response fatigue on estimation and identifiability of treatment effects. Stat Med. 2011;30(30):3560\u201372. https:\/\/doi.org\/10.1002\/sim.4377.","journal-title":"Stat Med"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-020-00860-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-020-00860-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-020-00860-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T23:30:12Z","timestamp":1612913412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-020-00860-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s11764-020-00860-4","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"type":"print","value":"1932-2259"},{"type":"electronic","value":"1932-2267"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"11 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NR declares that she has no conflict of interest. ECZ declares she has no conflict of interest. NA declares she has no conflict of interest. KO declares he has no conflict of interest. EST declares she has no conflict of interest. DK has no personal relationship to industry; her spouse serves on the scientific board of Vedanta Biosciences and as a consultant for Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}